Natasha F. Sabur

St. Michael's Hospital
Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Treatment of multidrug-resistant tuberculosis with bedaquiline, pretomanid, linezolid, and moxifloxacin following near-total gastrectomy.

Treatment of multidrug-resistant tuberculosis with bedaquiline, pretomanid, linezolid, and moxifloxacin following near-total gastrectomy.

Journal: ASM case reports

Published: February 06, 2026

The impact of non-TB mycobacterial co-isolation in patients with pulmonary TB.

The impact of non-TB mycobacterial co-isolation in patients with pulmonary TB.

Journal: IJTLD open

Published: August 19, 2025

Acquisition of bedaquiline and clofazimine resistance in association with a novel loss-of-function mutation in the pepQ gene during treatment of multidrug-resistant tuberculosis.

Acquisition of bedaquiline and clofazimine resistance in association with a novel loss-of-function mutation in the pepQ gene during treatment of multidrug-resistant tuberculosis.

Journal: ASM case reports

Published: June 28, 2025

Glomerulonephritis during Mycobacterium tuberculosis infection: scoping review.

Glomerulonephritis during Mycobacterium tuberculosis infection: scoping review.

Journal: BMC nephrology

Published: March 07, 2024

Disseminated Cryptococcus neoformans presenting with an isolated pleural effusion in a patient receiving temozolomide and long-term steroids.

Disseminated Cryptococcus neoformans presenting with an isolated pleural effusion in a patient receiving temozolomide and long-term steroids.

Journal: BMJ case reports

Published: November 22, 2023

Characteristics of and treatment outcomes in rifampicin-intolerant patients.

Characteristics of and treatment outcomes in rifampicin-intolerant patients.

Journal: IJTLD open

Published: September 24, 2023

Interferon-γ Release Assay Test Performance among Immunosuppressant Drug Recipients.

Interferon-γ Release Assay Test Performance among Immunosuppressant Drug Recipients.

Journal: Annals of the American Thoracic Society

Published: November 28, 2022

Hepatotoxicity and tuberculosis treatment outcomes in chronic liver disease.

Hepatotoxicity and tuberculosis treatment outcomes in chronic liver disease.

Journal: Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada

Published: September 13, 2022

Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010-2016.

Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010-2016.

Journal: Emerging infectious diseases

Published: August 23, 2022

Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB).

Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB).

Journal: BMC infectious diseases

Published: November 02, 2020

An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB/RIF and Alere Determine TB LAM Ag.

An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB/RIF and Alere Determine TB LAM Ag.

Journal: Journal of clinical microbiology

Published: May 08, 2020

Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010-2016.

Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010-2016.

Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada

Published: April 14, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026